Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Bullous Dermatoses

sorafenib has been researched along with Bullous Dermatoses in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawai, K; Minemura, M; Nakajima, T; Sugiyama, T; Tajiri, K1
Botella-Estrada, R; Echeverría, B; Guillén, C; Llombart, B1
Komine, M; Maekawa, T; Maki, N; Murata, S; Ohtsuki, M; Takatsuka, Y1

Other Studies

3 other study(ies) available for sorafenib and Bullous Dermatoses

ArticleYear
Sneddon-Wilkinson disease induced by sorafenib in a patient with advanced hepatocellular carcinoma.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:6

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Skin Diseases, Vesiculobullous; Sorafenib

2015
[Palmoplantar cutaneous reaction to sorafenib].
    Actas dermo-sifiliograficas, 2009, Volume: 100, Issue:8

    Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Skin Diseases, Vesiculobullous; Sorafenib

2009
Pustular eruption induced by sorafenib in a case of psoriasis vulgaris.
    The Journal of dermatology, 2013, Volume: 40, Issue:4

    Topics: Aged; Asian People; Humans; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Psoriasis; Severity of Illness Index; Skin Diseases, Vesiculobullous; Sorafenib

2013